ராஜீவ் கோசில News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ராஜீவ் கோசில. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ராஜீவ் கோசில Today - Breaking & Trending Today
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Enteris BioPharma to Host Webinar on High Potency Active Pharmaceutical Ingredients in Oral Drug Development prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
ਨਵੇਂ ਵਿੱਤੀ ਰੁਝਾਨ ਆਮ ਲੋਕਾਂ ਲਈ ਖ਼ਤਰਨਾਕ punjabitribuneonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from punjabitribuneonline.com Daily Mail and Mail on Sunday newspapers.
Enteris BioPharma Completes Expansion of Manufacturing Facility and Announces Launch of CDMO Business Segment CDMO Business Driven by Custom Solutions from Bench to Market for the Development and Manufacture of Difficult to Formulate Drugs and Highly Potent Compounds News provided by Share this article Share this article BOONTON, N.J., May 3, 2021 /PRNewswire/ Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the expansion of its Boonton, NJ manufacturing facility and the launch of its CDMO business segment, providing custom solutions for the formulation, development and manufacturing of solid oral doses for difficult to formulate BCS III and IV compounds, including peptides and highly potent compounds. Enteris now provides bench to market services, including the development, manufacture, ....
Corporate Highlights Closed four transactions in 2020 deploying $34.8 million; additional $8.1 million deployed to existing borrowers Income producing assets as of December 31, 2020 reached an all-time high of $206.0 million, accompanied by strong credit trends Closed a $9.0 million transaction in March 2021, deploying $7.1 million Received two milestone payments from Cara Therapeutics totaling $5.0 million, with SWK retaining $3.0 million and the other $2.0 million being remitted to Enteris prior owner. Specialty Finance Segment Highlights: For the fourth quarter of 2020, finance portfolio realized yield was 16.6%, compared to 20.4% for the fourth quarter of 2019 For the fourth quarter of 2020, finance portfolio effective yield was 13.8%, a 60 bps increase compared with 13.2% in the fourth quarter of 2019 ....